ASCO names Gralow new CMO; plus moves at Genenta, Vor, Exscientia, OncoMyx, Quanterix, Actinium, AbCellera and KBP

The American Society of Clinical Oncology named Julie Gralow CMO, effective Feb. 15, 2021. Gralow, a professor of medical oncology and director of breast medical oncology at the University of Washington, Fred Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance, will succeed CMO and EVP Richard Schilsky, who is retiring. 

Italian gene therapy play Genenta Science s.r.l. appointed Stephen Squinto as chairman. Squinto, an executive partner at OrbiMed Advisors and former co-founder and CEO of Passage Bio Inc. (NASDAQ:PASG), succeeds Pierluigi Paracchi, who will remain Genenta’s CEO. ...